News & Events

News, industry insights and noteworthy events.

At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.

For media or press inquiries, please email us.

Contact Us

All Articles

  1. Tanner Pharma Group to Distribute Novel Diagnostic Test in Latin America

    TannerLAC UK Limited (“TannerLAC”), a part of Tanner Pharma Group, and Epimune Diagnostics (“Epimune”), a molecular diagnostic company, recently partnered to distribute the innovative diagnostic test, i.Mune TBNK®, in Latin America. i.Mune TBNK® is an IVD product that quantifies CD3+, CD4+, CD8+ T-, B- and NK lymphocytes in fresh blood or a dried blood spot…

    Read More
  2. Tanner Pharma Group Directors to Key International Healthcare Conferences

    Directors from Tanner Pharma Group will attend key international healthcare conferences in the coming weeks. Connect with our team members directly or via conference platforms to schedule meetings. We look forward to meeting with you. 27 – 29 July 2022 | Miami Beach Convention Center, Miami, FL Florida International Medical Expo is the Americas’ leading medical…

    Read More
  3. Managed access programs explained with TannerMAP

    Tanner’s Managed Access Program (MAP) division specializes in increasing access to life-saving treatments for patients who would otherwise be unable to access them, either via pre-approval access programs or global donation programs. TannerMAP also develops and delivers access programs for specific medicines from manufacturer partners. TannerMAP focuses on providing access to medicines that are commercialized…

    Read More
  4. Crisis response: meeting urgent demand for PPE and tests in the pandemic

    Originally featured on Pharmaceutical Technology. As Covid-19 swept across the world, Tanner Pharma Group started receiving near-insurmountable requests from multiple industries for testing kits and PPE. We find out how the company met demand through the development of a dedicated subdivision, TannerGMS, and learn what the future holds for diagnostics and PPE as we emerge from…

    Read More
  5. Partnering to Respond to a Possible Nuclear Threat

    Originally posted on May 25, 2022 on PharmaceuticalExecutive.com. Steve Scalia, Bob Mulroy, John L. McManus Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity. In early March, an explosion at Ukraine’s Zaporizhzhia nuclear power plant after intense Russian shelling had the world…

    Read More
  6. Birmingham Biotech and Tanner Pharma Group Enter Distribution Partnership for Innovative Nasal Spray in Latin America

    Birmingham, UK, 31st May 2022 / Sciad Newswire / Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and TannerLAC UK Limited (“TannerLAC”), a part of Tanner Pharma Group, have entered into a license agreement for the distribution of Norizite™ Nasal Spray in Latin America. TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner…

    Read More
  7. Tanner Pharma Expands Operations to Ireland

    Tanner Pharma announced today its expansion to Ireland with the opening of a new office space in Cork, the country’s third largest city. The new location was selected after many months of travel and research by Tanner’s executive team. With the withdrawal of the United Kingdom from the European Union, it was essential for Tanner to maintain a presence in…

    Read More
  8. Charlotte Company Stockpiling Drug in Europe to Treat Radiation and Chemical Exposure

    The move was made due to Russia’s invasion of Ukraine and the escalating potential for incidents that would require the medication. Originally posted on WCNC.com. Author: Curtis Carden | Published: 9:25 PM EDT April 4, 2022 | Updated: 11:27 PM EDT April 4, 2022 CHARLOTTE, N.C. — An international distributor of medicines, based in Charlotte, is upping its…

    Read More
  9. Q1 2022 Global Team Event!

    Read More
  10. Albireo Completes Enrollment in Pivotal Phase 3 ASSERT Study of BylvayTM (odevixibat) in Alagille Syndrome

    Tanner Pharma Group has partnered with Albireo to manage the ALGS Expanded Access Program. Source: Albireo Pharma, Inc. BOSTON, March 29, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced the completion of patient enrollment in the ASSERT study, a Phase 3 pivotal trial of…

    Read More
  11. Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine

    Leukine is FDA Approved to Treat Acute Radiation Syndrome (ARS) and Recommended in EMEA/CPMP Guidance to Treat Systemic Sulfur Mustard (HD) Gas Exposure LONDON–(BUSINESS WIRE)–Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine (sargramostim, yeast-derived rhuGM-CSF) to be held in Europe. This action is being…

    Read More
  12. Tanner Pharma Featured in the EDPNC’s 2021 Annual Report as Top Global Reach Exporter

    Read original publication on the EDPNC website. TRADE TEAM HELPS COMPANY IMPROVE GLOBAL ACCESS TO MEDICINES Headquartered in Charlotte, Tanner Pharma Group is a rapidly growing company with local roots and a global mission — to improve lives by increasing access to medicine around the world. Tanner teams up with U.S. pharmaceutical, biotech and health…

    Read More
  13. Early access programs: how real-world data capture helps regulatory approval

    Originally featured on Pharmaceutical Technology. While clinical trials can prove that a medical product is safe and effective in a controlled environment, the vital data for how a new medicine will perform in the real world is often lacking. We learn more about the connection between real-world data capture and early access programs, and the…

    Read More
  14. Global access programs: meeting urgent medical needs

    Originally featured on Pharmaceutical Technology. The mission of Tanner’s global access programs (GAP) division is to meet immediate medical needs for patients regardless of their geographical location. The division’s work includes addressing medicine market withdrawal, post-clinical trial solutions, mitigating drug shortages and managing medicine supply on a Named Patient basis. To learn more, we speak…

    Read More
  15. The benefits of early access programs

    Originally featured on Pharmaceutical Technology. Patients living with critical illnesses may require access to medicines that are unavailable to them for various reasons. Life-changing treatments might take years to pass the necessary regulatory approvals in certain countries, if at all. Tanner enables patient access to innovative medicines through the creation and implementation of early access programs.…

    Read More
  16. Minimizing disruption to the pharma supply chain

    Originally featured on Pharmaceutical Technology. Just-in-time deliveries are of paramount importance in the pharmaceutical industry. While the global pandemic has caused significant disruption to the supply chain, it is still possible to maintain a robust and reliable delivery network to minimize delays in shipments. We learn how Tanner Pharma Group has successfully maneuvered supply chain challenges…

    Read More
  17. Increasing the availability of medical products in Latin America

    Originally featured on Pharmaceutical Technology. The availability of pharmaceuticals can be limited in certain emerging markets around the world. Latin America is one such region, where regulatory, political, and economic obstacles can present challenges with commercial launch and supply. As one of Tanner’s first divisions, TannerLAC was established to address these issues and ensure that supplies…

    Read More
  18. A mission to improve patient access: Tanner Pharma Group

    Originally featured on Pharmaceutical Technology. Tanner Pharma Group was founded two decades ago specifically to improve patient access to life-saving medicines. The company operates around the world, working with manufacturers, non-profit organizations, physicians and health authorities to get treatments to patients on the ground while navigating issues that include regulations, languages, supplies, and logistics. We speak…

    Read More

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.